SPDR S&P Biotech ETF
456 hedge funds and large institutions have $7.41B invested in SPDR S&P Biotech ETF in 2020 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 150 increasing their positions, 147 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
456
Holders Change
-16
Holders Change %
-3.39%
% of All Funds
10.07%
Holding in Top 10
14
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+27.27%
% of All Funds
0.31%
New
68
Increased
150
Reduced
147
Closed
78
Calls
$650M
Puts
$1.68B
Net Calls
-$1.03B
Net Calls Change
+$1.21B
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$755M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$582M |
| 3 |
Goldman Sachs
New York
|
+$515M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$269M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$198M |
